Atria Investments’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Buy
30,220
+608
+2% +$5.58K ﹤0.01% 1917
2026
Q1
$275K Sell
29,612
-2,535
-8% -$24.9K ﹤0.01% 1808
2025
Q4
$225K Sell
32,147
-8,930
-22% -$56.2K ﹤0.01% 1911
2025
Q3
$235K Sell
41,077
-1,208
-3% -$6.45K ﹤0.01% 1860
2025
Q2
$202K Buy
42,285
+1,067
+3% +$6.13K ﹤0.01% 1922
2025
Q1
$357K Buy
41,218
+10,960
+36% +$115K ﹤0.01% 1521
2024
Q4
$367K Sell
30,258
-2,159
-7% -$30.2K ﹤0.01% 1480
2024
Q3
$545K Buy
32,417
+7,408
+30% +$122K 0.01% 1276
2024
Q2
$391K Buy
+25,009
New +$348K 0.01% 1432
2020
Q1
– Sell
-7,170
Closed -$234K – 962
2019
Q4
$234K Buy
+7,170
New +$236K 0.01% 1084

Other funds holding NEOG

Atria Investments's NEOG Position: Q2 2026 in Review

Atria Investments increased its Neogen (NEOG) stake by 2.1% in Q2 2026, buying an estimated $5.58K and bringing the position to 30,220 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #1917.

Atria Investments first reported a position in NEOG in Q4 2019 and has held it in 10 quarters since. The position peaked at $545K in Q3 2024. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Atria Investments held 30,220 shares of Neogen worth $272K as of Q2 2026.
  • Atria Investments bought 608 Neogen shares in Q2 2026, an estimated $5.58K.
  • Neogen made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1917 holding.
  • Atria Investments first reported a position in Neogen in Q4 2019 and has held it in 10 quarters since.
  • Atria Investments's Neogen position peaked at $545K in Q3 2024.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.